Rachael L Emery, CF | |
105 Leonard Ln, Woodstock, VT 05091-7978 | |
(802) 291-0280 | |
Not Available |
Full Name | Rachael L Emery |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 105 Leonard Ln, Woodstock, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184318404 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rachael L Emery, CF 105 Leonard Ln, Woodstock, VT 05091-7978 Ph: (802) 291-0280 | Rachael L Emery, CF 105 Leonard Ln, Woodstock, VT 05091-7978 Ph: (802) 291-0280 |
News Archive
Around 600,000 Austrians suffer from diabetes. This condition is frequently associated with serious retinal disorders. Along with age-related macular degeneration, diabetic retinal degeneration is one of the most common causes of blindness. The Department of Ophthalmology and Optometry at MedUni Vienna was chosen by the European Society of Retina Specialists (EURETINA) to coordinate the development of up-to-date treatment and diagnostic guidelines.
The Securities and Exchange Commission has sued a House committee and its staff director in federal court to enforce subpoenas for documents and testimony about possible tipping of confidential government information about a planned change in Medicare reimbursement rates that reached investors and sent health insurance stocks soaring.
Researchers recently found that a single dose of a vaccine being developed by Medicago, Inc., a publicly traded biopharmaceutical company, could protect against not only the avian influenza (H5N1) strain it was designed for, but also another H5N1 strain and a strain of a different flu subtype, called H2N2.
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the first lots of Fluzone (Influenza Virus Vaccine) for the 2013-2014 season have been released by the U.S. Food and Drug Administration for U.S. distribution and were shipped July 24.
Case Western Reserve University has granted a two-year technology transfer option to a research spinoff company developing a hand-held device that diagnoses malaria more quickly, simply and affordably than existing methods.
› Verified 2 days ago